Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-18-054993
Filing Date
2018-10-23
Accepted
2018-10-23 17:10:43
Documents
1
Period of Report
2018-10-19

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv505272_form4.html 4  
1 OWNERSHIP DOCUMENT tv505272_form4.xml 4 4455
  Complete submission text file 0001144204-18-054993.txt   6117
Mailing Address 5 WEST FORSYTH STREET SUITE 200 JACKSONVILLE FL 32202
Business Address 5 WEST FORSYTH STREET SUITE 200 JACKSONVILLE FL 32202 (904) 516-5436
Marker Therapeutics, Inc. (Issuer) CIK: 0001094038 (see all company filings)

EIN.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2925 RICHMOND AVENUE SUITE 1274 HOUSTON TX 77098
Business Address
Vera Juan (Reporting) CIK: 0001755495 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37939 | Film No.: 181134687